Aptevo Therapeutics Inc. (APVO)
$1.84+2.79%Close
BUYRECOVERY · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.61
- P/E (TTM)
- -0.01
- Short % float
- 10.42%
- Days to cover
- 1.7
- SI change
- -36.4%
- 1W
- +2.22%
- 1M
- +1.10%
- vs SPY 1W
- +1.80%
- vs SPY 1M
- -0.96%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on APVO?
- LOPJLB’s latest quantitative signal on Aptevo Therapeutics Inc. (APVO) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is APVO in?
- Aptevo Therapeutics Inc. (APVO) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Aptevo Therapeutics Inc. (APVO) do?
- Aptevo Therapeutics Inc. is a clinical-stage biotechnology company primarily focused on pioneering immunotherapeutic agents for a variety of cancer treatments across the United States. Its foremost investigational drug, APVO436, is a bispecific antibody crafted to engage T-cells, which is currently undergoing a Phase 1b clinical study for acute myeloid leukemia and myelodysplastic syndromes. Be…